Resolution of hypergastrinaemia after parathyroidectomy in multiple endocrine neoplasia syndrome type I (MEN type I)

Clin Endocrinol (Oxf). 1987 Jun;26(6):693-8. doi: 10.1111/j.1365-2265.1987.tb00827.x.

Abstract

The treatment of choice for gastric acid hypersecretion in MEN type I has now changed from total gastrectomy to the long-term administration of H2 receptor blockers or similar agents. However, the importance of parathyroidectomy for the concomitant hypercalcaemia is not fully realized. A case is reported of a subject with MEN type I, who was initially treated with parathyroidectomy and H2 receptor blockade. Following parathyroidectomy, there was a rapid fall of the markedly elevated gastrin levels to the upper limit of the normal range. During follow-up of 2.5 years, there has been no increase in serum gastrin, and the subject's gastric symptoms have resolved, despite the cessation of H2 blockade. Infusion of calcium to pre-operative levels and superimposed secretin stimulation after this period of time closely reproduced the pre-operative hypergastrinaemia. On screening, the subject's only child was found to have hypercalcaemia but normal serum gastrin levels and pituitary function; parathyroidectomy has been carried out. No abnormality of gastrin secretion has been found during follow-up. This case highlights the importance of early parathyroidectomy in this syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Calcium / blood
  • Female
  • Follow-Up Studies
  • Gastrins / blood*
  • Humans
  • Multiple Endocrine Neoplasia / blood
  • Multiple Endocrine Neoplasia / genetics
  • Multiple Endocrine Neoplasia / surgery*
  • Parathyroid Glands / surgery*
  • Parathyroid Neoplasms / surgery*

Substances

  • Gastrins
  • Calcium